| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(08)60607-8 |
| P698 | PubMed publication ID | 18440414 |
| P2093 | author name string | Jonathan Mermin | |
| David M Moore | |||
| P2860 | cites work | Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies | Q34228103 |
| Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis | Q36560027 | ||
| WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda | Q38878096 | ||
| Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy | Q40799722 | ||
| Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
| Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. | Q46491049 | ||
| Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model | Q46623836 | ||
| Performance of Immunologic Responses in Predicting Viral Load Suppression | Q57259706 | ||
| P433 | issue | 9622 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1396-1397 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Monitoring antiretroviral failure in resource-poor settings | |
| P478 | volume | 371 |
| Q84420336 | Five-year outcomes of the China National Free Antiretroviral Treatment Program |
| Q33611305 | Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort |
| Q35217495 | Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness |
| Q36877987 | Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings |
Search more.